We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

117 hedge funds and large institutions have $122M invested in Cardiff Oncology in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 40 increasing their positions, 16 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,133% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 3

258% more capital invested

Capital invested by funds: $34.1M → $122M (+$87.8M)

253% more call options, than puts

Call options by funds: $4.64M | Put options by funds: $1.32M

150% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 16

41% more funds holding

Funds holding: 83 → 117 (+34)

14.82% more ownership

Funds ownership: 27.41% → 42.23% (+15%)

Holders
117
Holders Change
+34
Holders Change %
+40.96%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
40
Reduced
16
Closed
3
Calls
$4.64M
Puts
$1.32M
Net Calls
+$3.32M
Net Calls Change
+$1.54M

Top Buyers

1
CC
Commodore Capital
New York
+$16.8M
2
O
OrbiMed
New York
+$4.81M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.04M
4
LCM
Laurion Capital Management
New York
+$1.8M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.59M

Top Sellers

1
Two Sigma Advisers
Two Sigma Advisers
New York
-$989K
2
BC
BIT Capital
Germany
-$676K
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$635K
4
Renaissance Technologies
Renaissance Technologies
New York
-$373K
5
Marshall Wace
Marshall Wace
United Kingdom
-$251K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$607K +$437K +139,854 New
BFM
27
Boothbay Fund Management
New York
$564K +$406K +129,960 New
AIC
28
AWM Investment Company
New York
$462K +$333K +106,435 New
Two Sigma Investments
29
Two Sigma Investments
New York
$457K -$248K -79,346 -43%
Charles Schwab
30
Charles Schwab
California
$441K -$61.4K -19,629 -16%
CC
31
Callan Capital
California
$441K +$31.6K +10,108 +11%
Citadel Advisors
32
Citadel Advisors
Florida
$301K +$58.8K +18,807 +37%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$297K – – –
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$292K -$635K -203,292 -75%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$286K +$189K +60,519 +1,128%
Marshall Wace
36
Marshall Wace
United Kingdom
$272K -$251K -80,426 -56%
Barclays
37
Barclays
United Kingdom
$272K +$29.7K +9,507 +18%
Creative Planning
38
Creative Planning
Kansas
$265K +$23.1K +7,399 +14%
American Century Companies
39
American Century Companies
Missouri
$234K +$19.2K +6,140 +13%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$231K +$32.2K +10,290 +24%
Capstone Investment Advisors
41
Capstone Investment Advisors
New York
$222K – – –
VF
42
Virtu Financial
New York
$222K +$160K +51,181 New
Deutsche Bank
43
Deutsche Bank
Germany
$215K +$155K +49,566 New
JGC
44
J. Goldman & Co
New York
$205K +$148K +47,250 New
Blackstone Inc
45
Blackstone Inc
New York
$181K +$130K +41,700 New
XT
46
XTX Topco
Cayman Islands
$177K -$249K -79,621 -66%
AQR Capital Management
47
AQR Capital Management
Connecticut
$176K +$30.5K +9,770 +32%
I
48
INVST
Indiana
$156K +$42.2K +13,500 +60%
HighTower Advisors
49
HighTower Advisors
Illinois
$148K +$59K +18,880 +123%
Bank of America
50
Bank of America
North Carolina
$148K -$35.5K -11,352 -25%
1
2
3 4 5

CRDF Hedge Fund Activity: Q4 2024 in Review

117 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2024, worth a combined $122M — up 258% from $34.1M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new CRDF positions and 3 closed out — a net gain of 34 holders — while 40 added to existing stakes and 16 trimmed.

The largest buyer was Commodore Capital, opening a new position worth an estimated $16.8M. The largest seller was Two Sigma Advisers, cutting an estimated $989K.

  • 117 institutional investors held Cardiff Oncology (CRDF) as of Q4 2024, up from 83 in Q3 2024.
  • Funds reported $122M of Cardiff Oncology stock for Q4 2024, up 258% quarter-over-quarter.
  • 37 funds opened new Cardiff Oncology positions in Q4 2024 and 3 closed out, a net change of +34 holders.
  • The largest Cardiff Oncology buyer in Q4 2024 was Commodore Capital, an estimated $16.8M added.
  • The largest Cardiff Oncology seller in Q4 2024 was Two Sigma Advisers, an estimated $989K sold.

Based on aggregated 13F filings for Q4 2024.